Protecting Intestinal Barrier Health
Protecting Intestinal Barrier Health
Protectors of Intestinal Integrity
Our mission is to develop and commercialize novel therapeutics that target diseases resulting from a loss of gastrointestinal barrier integrity.
Science
Applying Established Science to Tackle New Challenges
We identify the role of intestinal barrier biology in human disease and develop novel therapeutics that target and improve the integrity of the intestinal barrier.
Our lead program LB1148 is being investigated in a Phase 2 study to evaluate its effects on intra-abdominal adhesions and return of gastrointestinal function in subjects undergoing elective bowel resection (PROFILE).
Science
Applying Established Science to Tackle New Challenges
We identify the role of intestinal barrier biology in human disease and develop novel therapeutics that target and improve the integrity of the intestinal barrier.
Our lead program LB1148 is being investigated in a Phase 2 study to evaluate its effects on intra-abdominal adhesions and return of gastrointestinal function in subjects undergoing elective bowel resection (PROFILE).
Research
Studying Impacts on Intestinal Integrity
Leveraging more than three decades of research and 15 years of our own internal efforts, we are advancing therapies to help patients with acute and chronic conditions associated with intestinal barrier disruption.
Research
Studying Impacts on Intestinal Integrity
Leveraging more than three decades of research and 15 years of our own internal efforts, we are advancing therapies to help patients with acute and chronic conditions associated with intestinal barrier disruption.